The lpg cellu m6 keymodule gets fda clearance for treating lymphedema - free-press-release.com
The LPG Cellu M6 Keymodule Gets FDA Clearance for Treating Lymphedema - Free-Press-Release.com
The LPG Cellu M6 Keymodule Gets FDA Clearance for Treating Lymphedema The FDA has just given the Class 1 Cellu M6 Keymodule, manufactured by LPG, Inc. (the world leader in connective tissue technology), full FDA clearance for treating Lymphedema. For_Immediate_Release:
Miami, FL – According to the World Health Organization,
Lymphedema afflicts hundreds of millions worldwide. Of
47% Reduction in Cellulite in Just 9 Minutes! See
these, the US Department of Health and Human Services
estimates more than 300 million are American. Variousforms of massage are used to treat this painful condition,
but none really have enough consistency or depth-of-
action to produce results. But now one does. The Food and
Vetenskapligt bevisat resultat! LPG-Endermologie
Drug Administration (FDA), has just given the Class 1 Cellu
M6 Keymodule, manufactured by LPG, Inc. (a medical
device company renowned as the world leader in
connective tissue technology), full FDA clearance for
Localized Hardening of Your Parts Lower Cost
Lymphedema. The new claims are as follows:
• Reduction of secondary Lymphedema of the arm (SLA)
post mastectomy (RX only)• Improvement of secondary Lymphedema (RX only)
• Improvement of lymphatic circulation in the treated area (RX only)
For this FDA clearance, LPG presented well-documented, scientifically proven clinical results showing the
Technology’s efficacy on the body’s circulatory, anti-edematous and dermatrophic systems. Along with these
published studies, multimodal clinical studies examining the efficacy and durability of the traditional ManualLymphatic Drainage (MLD) and Compression Bandaging (CB) versus the non-invasive LPG Treatment were
conducted by Neil Piller, M.D., Professor for Lymphology at the Lymphedema Assessment Clinic of Flinders
University Medical Center in South Australia.
Michel Van Welden, the Chief Executive Officer of Techno-Derm (LPG’s exclusive US distributor), explains, "Dr.
Piller’s research demonstrates that LPG Technology offers an all-inclusive, standardized therapy for SLA pathology –with greater consistency, efficacy and faster results than MLD – which confirms that LPG devices are essential for
The research concluded that the LPG Treatment showed significant decreases in perometry (18%), bio-impedance
(23.5%), and tissue softening in half the time as the MLD control group and with a sustained effect. What’s that
mean? That LPG’s FDA cleared Cellu M6 Keymodule presents a lastingly effective solution for millions ofLymphedema sufferers around the world. Lymphedema occurs whenever lymph nodes have been damaged - so
although this study examines the Cellu M6 Keymodule’s treatment of mastectomy Lymphedema – it’s
also ideal for Lymphedemas resulting from lumpectomies, radiation treatments and many other procedures.
Company Information:LPG Technology is marketed and distributed by Techno-Derm, LLC, (DBA: LPG America), 10800 Biscayne Blvd.,
Ste. 850 in Miami, Florida. For more on LPG treatments and LPG’s FDA-cleared , visit
To view a copy of Piller’s study, learn more about LPG’s FDA Lymphedema claims or schedule an interview with a
http://www.free-press-release.com/news/200812/1229457538.html
The LPG Cellu M6 Keymodule Gets FDA Clearance for Treating Lymphedema - Free-Press-Release.com
To view a copy of Piller’s study, learn more about LPG’s FDA Lymphedema claims or schedule an interview with aCompany representative, please contact Rebecca Hausen at 305-335-8696 or by email revcom.group@gmail.com.
For more information:
3500 Coral Way, Ste. 1002 Miami, FL 33145 Representing www.cellum6.com
l ted Artic
Link to this: http://www.free-press-release.com/news/200812/1229457538.html
L ave a Com p ess rele p ess rele
All press release information on this site, including free press release and premier
press release, is solely based on what our users submit. Free-Press-Release.com
http://www.free-press-release.com/news/200812/1229457538.html
The LPG Cellu M6 Keymodule Gets FDA Clearance for Treating Lymphedema - Free-Press-Release.com
disclaims that any right and,is solely based on what our users submit. Free-
Press-Release.com disclaims that any right and responsibility for the information
go to the user who submit the press release. Some press release may be
confusing without additional explanation. You should contact the provider withany questions about the information presented. In case some press release
damages your benefits or violate your rights in any way, please contact us and
http://www.free-press-release.com/news/200812/1229457538.html
The Visual Matrix: The case of Mimar Sinan Project Site Bilkent University, Turkeyhttp://www.art.bilkent.edu.tr/iaed Abstract. This paper introduces a web-based ‘visual reference system’ model for archi-tectural education and research. The system utilizes visualization to aid in spatial com-prehension and comparative analysis of abstract architectural concepts. The systemestablishes a
Effect of Efavirenz on the Pharmacokinetics of Ethinyl Estradiol and Norgestimate in Healthy Female Subjects H. Sevinsky, T. Eley, B. He, A. Persson, D. Garner, C. Yones, R. Nettles, R. Bertz and J. Zhang Bristol-Myers Squibb Research and Development, Princeton, NJ USA Introducti Introducti on Results (Cont’d) Results (Cont’d) Results (Cont’d) Efavirenz (EFV) is